These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

632 related articles for article (PubMed ID: 29140481)

  • 1. Excessive burden of lysosomal storage disorder gene variants in Parkinson's disease.
    Robak LA; Jansen IE; van Rooij J; Uitterlinden AG; Kraaij R; Jankovic J; ; Heutink P; Shulman JM
    Brain; 2017 Dec; 140(12):3191-3203. PubMed ID: 29140481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic modifiers of risk and age at onset in GBA associated Parkinson's disease and Lewy body dementia.
    Blauwendraat C; Reed X; Krohn L; Heilbron K; Bandres-Ciga S; Tan M; Gibbs JR; Hernandez DG; Kumaran R; Langston R; Bonet-Ponce L; Alcalay RN; Hassin-Baer S; Greenbaum L; Iwaki H; Leonard HL; Grenn FP; Ruskey JA; Sabir M; Ahmed S; Makarious MB; Pihlstrøm L; Toft M; van Hilten JJ; Marinus J; Schulte C; Brockmann K; Sharma M; Siitonen A; Majamaa K; Eerola-Rautio J; Tienari PJ; ; Pantelyat A; Hillis AE; Dawson TM; Rosenthal LS; Albert MS; Resnick SM; Ferrucci L; Morris CM; Pletnikova O; Troncoso J; Grosset D; Lesage S; Corvol JC; Brice A; Noyce AJ; Masliah E; Wood N; Hardy J; Shulman LM; Jankovic J; Shulman JM; Heutink P; Gasser T; Cannon P; Scholz SW; Morris H; Cookson MR; Nalls MA; Gan-Or Z; Singleton AB
    Brain; 2020 Jan; 143(1):234-248. PubMed ID: 31755958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The burden of rare damaging variants in hereditary atypical parkinsonism genes is increased in patients with Parkinson's disease.
    Kim YJ; Lee J; Kim NY; Hong S; Cho YS; Yoon J
    Neurobiol Aging; 2021 Apr; 100():118.e5-118.e13. PubMed ID: 33423827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Analysis of Prosaposin, the Lysosomal Storage Disorder Gene in Parkinson's Disease.
    Chen YP; Gu XJ; Ou RW; Zhang LY; Hou YB; Liu KC; Cao B; Wei QQ; Song W; Zhao B; Wu Y; Cheng JQ; Shang HF
    Mol Neurobiol; 2021 Apr; 58(4):1583-1592. PubMed ID: 33219486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysosomal storage disorders and Parkinson's disease: Gaucher disease and beyond.
    Shachar T; Lo Bianco C; Recchia A; Wiessner C; Raas-Rothschild A; Futerman AH
    Mov Disord; 2011 Aug; 26(9):1593-604. PubMed ID: 21618611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The GBA variant E326K is associated with Parkinson's disease and explains a genome-wide association signal.
    Berge-Seidl V; Pihlstrøm L; Maple-Grødem J; Forsgren L; Linder J; Larsen JP; Tysnes OB; Toft M
    Neurosci Lett; 2017 Sep; 658():48-52. PubMed ID: 28830825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging links between pediatric lysosomal storage diseases and adult parkinsonism.
    Ysselstein D; Shulman JM; Krainc D
    Mov Disord; 2019 May; 34(5):614-624. PubMed ID: 30726573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations.
    Alcalay RN; Levy OA; Waters CC; Fahn S; Ford B; Kuo SH; Mazzoni P; Pauciulo MW; Nichols WC; Gan-Or Z; Rouleau GA; Chung WK; Wolf P; Oliva P; Keutzer J; Marder K; Zhang X
    Brain; 2015 Sep; 138(Pt 9):2648-58. PubMed ID: 26117366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease.
    Neumann J; Bras J; Deas E; O'Sullivan SS; Parkkinen L; Lachmann RH; Li A; Holton J; Guerreiro R; Paudel R; Segarane B; Singleton A; Lees A; Hardy J; Houlden H; Revesz T; Wood NW
    Brain; 2009 Jul; 132(Pt 7):1783-94. PubMed ID: 19286695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Lysosomal Gene Variants in Modulating GBA-Associated Parkinson's Disease Risk.
    Straniero L; Rimoldi V; Monfrini E; Bonvegna S; Melistaccio G; Lake J; Soldà G; Aureli M; Shankaracharya ; Keagle P; Foroud T; Landers JE; Blauwendraat C; Zecchinelli A; Cilia R; Di Fonzo A; Pezzoli G; Duga S; Asselta R
    Mov Disord; 2022 Jun; 37(6):1202-1210. PubMed ID: 35262230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanopore sequencing of the glucocerebrosidase (GBA) gene in a New Zealand Parkinson's disease cohort.
    Graham OEE; Pitcher TL; Liau Y; Miller AL; Dalrymple-Alford JC; Anderson TJ; Kennedy MA
    Parkinsonism Relat Disord; 2020 Jan; 70():36-41. PubMed ID: 31809948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The contribution of Niemann-Pick SMPD1 mutations to Parkinson disease in Ashkenazi Jews.
    Dagan E; Schlesinger I; Ayoub M; Mory A; Nassar M; Kurolap A; Peretz-Aharon J; Gershoni-Baruch R
    Parkinsonism Relat Disord; 2015 Sep; 21(9):1067-71. PubMed ID: 26169695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted sequencing of Parkinson's disease loci genes highlights SYT11, FGF20 and other associations.
    Rudakou U; Yu E; Krohn L; Ruskey JA; Asayesh F; Dauvilliers Y; Spiegelman D; Greenbaum L; Fahn S; Waters CH; Dupré N; Rouleau GA; Hassin-Baer S; Fon EA; Alcalay RN; Gan-Or Z
    Brain; 2021 Mar; 144(2):462-472. PubMed ID: 33349842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells.
    McNeill A; Magalhaes J; Shen C; Chau KY; Hughes D; Mehta A; Foltynie T; Cooper JM; Abramov AY; Gegg M; Schapira AH
    Brain; 2014 May; 137(Pt 5):1481-95. PubMed ID: 24574503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rare lysosomal enzyme gene SMPD1 variant (p.R591C) associates with Parkinson's disease.
    Foo JN; Liany H; Bei JX; Yu XQ; Liu J; Au WL; Prakash KM; Tan LC; Tan EK
    Neurobiol Aging; 2013 Dec; 34(12):2890.e13-5. PubMed ID: 23871123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic convergence of Parkinson's disease and lysosomal storage disorders.
    Deng H; Xiu X; Jankovic J
    Mol Neurobiol; 2015; 51(3):1554-68. PubMed ID: 25099932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson's Disease.
    Benitez BA; Davis AA; Jin SC; Ibanez L; Ortega-Cubero S; Pastor P; Choi J; Cooper B; Perlmutter JS; Cruchaga C
    Mol Neurodegener; 2016 Apr; 11():29. PubMed ID: 27094865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revisiting the non-Gaucher-GBA-E326K carrier state: Is it sufficient to increase Parkinson's disease risk?
    Goldstein O; Gana-Weisz M; Cohen-Avinoam D; Shiner T; Thaler A; Cedarbaum JM; John S; Lalioti M; Gurevich T; Bar-Shira A; Mirelman A; Giladi N; Orr-Urtreger A
    Mol Genet Metab; 2019 Dec; 128(4):470-475. PubMed ID: 31662221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SMPD1 variants in Chinese Han patients with sporadic Parkinson's disease.
    Mao CY; Yang J; Wang H; Zhang SY; Yang ZH; Luo HY; Li F; Shi M; Liu YT; Zhuang ZP; Du P; Wang YH; Shi CH; Xu YM
    Parkinsonism Relat Disord; 2017 Jan; 34():59-61. PubMed ID: 27814975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in GBA-associated Parkinson's disease--Pathology, presentation and therapies.
    Barkhuizen M; Anderson DG; Grobler AF
    Neurochem Int; 2016 Feb; 93():6-25. PubMed ID: 26743617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.